Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
1.755
-0.085 (-4.62%)
At close: Jun 16, 2026, 4:00 PM EDT
1.780
+0.025 (1.42%)
After-hours: Jun 16, 2026, 5:27 PM EDT

Health Catalyst Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Health Catalyst stock has a consensus rating of "Buy" and an average price target of $1.75. The average 1-year stock price forecast is 0.28% lower than the current stock price, while the lowest is $1.00 (-43.02%) and the highest is $2.00 (+13.96%).

Price Target: $1.75 (-0.28%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$1.00$1.75$2.00$2.00
Change-43.02%-0.28%+13.96%+13.96%

Analyst Ratings

The average analyst rating for Health Catalyst stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy332222
Buy000000
Hold887765
Sell000000
Strong Sell000000
Total11119987

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$2
BuyMaintains$2+13.96%Jun 5, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 4, 2026
Stifel Nicolaus
Stifel Nicolaus
Hold
Maintains
$2
HoldMaintains$2+13.96%May 12, 2026
Stephens
Stephens
Hold
Maintains
$2$1.75
HoldMaintains$2$1.75-0.28%May 12, 2026
Piper Sandler
Piper Sandler
Hold
Reiterates
$2
HoldReiterates$2+13.96%May 12, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
263.11M
from 311.14M
Decreased by -15.43%
Revenue Next Year
246.77M
from 263.11M
Decreased by -6.21%
EPS This Year
0.04
from 0.18
Decreased by -76.66%
EPS Next Year
0.09
from 0.04
Increased by 119.66%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
241.93M276.24M295.94M306.58M311.14M263.11M
Revenue Growth
28.11%14.18%7.13%3.60%1.49%-15.43%
Gross Profit
117.76M135.56M134.83M141.79M154.63M135.55M
Gross Margin
48.68%49.07%45.56%46.25%49.70%51.52%
Operating Income
-113.92M-126.33M-92.88M-57.10M-43.17M-137.59M
Net Income
-153.21M-137.40M-118.15M-69.50M-177.97M-154.63M
EPS
----0.180.04
EPS Growth
-----35.71%-76.66%
Forward PE
--137.1921.566.6641.77
Free Cash Flow
24.68M13.04M17.88M29.45M10.73M48.00M
No. Analysts
-----7
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High265.0M
Avg263.1M
Low260.7M

Revenue Growth

Revenue Growth202620272028
High
-14.8%
Avg
-15.4%
Low
-16.2%

EPS Forecast

EPS202620272028
High0.22
Avg0.04
Low-0.05

EPS Growth

EPS Growth202620272028
High
22.2%
Avg
-76.7%
Low-